Reference
Kuwana M, et al. Complex pathophysiology of pulmonary hypertension associated with systemic sclerosis: Merits and demerits of aggressive treatment with pulmonary vasodilators. Clinical and Experimental Rheumatology 32 (Suppl. 81): S137-S138 abstr. PS333, 2014. Available from: URL: http://www.clinexprheumatol.org/a.asp?IDArchivio=156 [abstract] - Japan
Rights and permissions
About this article
Cite this article
Ambrisentan/beraprost/bosentan/sildenafil. Reactions Weekly 1545, 21 (2015). https://doi.org/10.1007/s40278-015-9112-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-9112-4